Agreed. Its becoming more apparent that they haven't progressed as close to a commercial deal as they appear to report and what MM has mentioned in media discussions
'Continued the design, synthesis and testing of new compounds under its HIV-1 program, with
the aim of identifying a next-generation lead anti-HIV-1 drug.
During the quarter ended 30 September 2020, Biotron has continued to undertake cell culture-based
assays on trial samples to further elucidate the mechanism of action of BIT225. The Company has
also continued to design, synthesise and screen new chemical entities with the aim of identifying a
follow-on, next-generation lead. '
It seems from the above that BIT225 compound Phase 2 trials weren't as 'successful' as they had hoped and reported
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report
Agreed. Its becoming more apparent that they haven't progressed...
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.85M |
Open | High | Low | Value | Volume |
2.2¢ | 2.3¢ | 2.2¢ | $8.562K | 389.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 228 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 1991719 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 365000 | 0.021 |
10 | 916111 | 0.020 |
10 | 1806701 | 0.019 |
10 | 1719892 | 0.018 |
6 | 614520 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 1991719 | 1 |
0.024 | 234999 | 2 |
0.025 | 150000 | 1 |
0.026 | 53847 | 1 |
0.027 | 162000 | 2 |
Last trade - 14.47pm 18/10/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |